SkinTE®would be the first new biologic commercially available in the U.S. for the treatment of a common chronic wound indication in nearly 30 years, if approved.SkinTE® is a first-in-class autologous ...
Wuxi, China, July 01, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that it has formally filed a complete ...
Preview this article 1 min Small-business grants available in July include a $20,000 option from Santander US and another grant possibility from Stanley. AI certifications can boost paychecks. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results